STERIS’ (TSE:STE – Free Report) – Analysts at Atb Cap Markets decreased their Q4 2025 earnings per share (EPS) estimates for STERIS’ in a research note issued on Thursday, June 27th. Atb Cap Markets analyst W. Syed now forecasts that the company will earn $0.03 per share for the quarter, down from their prior estimate of $0.04.
STERIS’ (TSE:STE – Get Free Report) last announced its quarterly earnings results on Wednesday, May 8th. The company reported C$0.55 earnings per share for the quarter, topping the consensus estimate of C$0.42 by C$0.13. The company had revenue of C$320.15 million for the quarter, compared to analyst estimates of C$289.75 million.
Read Our Latest Research Report on STE
STERIS’ Stock Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- EV Stocks and How to Profit from Them
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- Insider Trading – What You Need to Know
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- NYSE Stocks Give Investors a Variety of Quality Options
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
